Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Cancer Chemotherapy and Selective Drug Development - Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour Investigations, Brighton, England, October 24-28, 1983 (Paperback, Softcover reprint of the original 1st ed. 1984)
Loot Price: R4,322
Discovery Miles 43 220
|
|
Cancer Chemotherapy and Selective Drug Development - Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour Investigations, Brighton, England, October 24-28, 1983 (Paperback, Softcover reprint of the original 1st ed. 1984)
Series: Developments in Oncology, 23
Expected to ship within 10 - 15 working days
|
Over the past 30 years many significant advances have been made in
the management of a number of disseminated malignant diseases. The
prognosis for diseases such as childhood leukaemia, choriocarcinoma
and Hodgkin's disease has gradually been transformed as better anti
tumour agents have become available and their clinical use has been
refined. During the past 10 years the advent of new agents,
particularly cisplatin, bleomycin and the podophyllotoxins, has
allowed the cure of disseminated testicular tumours. This degree of
success has not, however, been achieved in the case of a number of
other common cancers. Ovarian carcinoma is tantalisingly
chemo-sensitive and although there are long term survivors from
disseminated disease, these are only a small proportion of the
total. Breast cancer, although "sensitive" to a multitude of drugs
appears to have yielded neither survival benefit, nor cure to the
efforts of therapists, while tumours such as those of the colon
remain stubbornly unresponsive. Against this backcloth it is
apparent that additional more selective treatments are needed if
further impact is to be made on the problem of cancer. The
development of such agents requires the integration of a
multidisciplinary effort encompassing the fields of chemistry,
biology and medicine. This symposium provided a forum for clinical
and preclinical sCientists, where current aspects of cancer
treatment were reviewed and approaches to the development of a new
generation of more selective anticancer drugs discussed.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Cancer
Susan E Pories, Marsha A Moses, …
Hardcover
R1,611
Discovery Miles 16 110
See more
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.